Female that have esophageal adenocarcinoma reduced commonly received neo-adjuvant procedures (78
Female that have esophageal adenocarcinoma reduced commonly received neo-adjuvant procedures (78 Treatment functions 1% against. 85.6%; Or 0.sixty, 95% CI 0.38–0.96, p = 0.033; Table 2), and that quicker have a tendency to contained chemoradiotherapy versus neo-adjuvant treatment regimens within the male people (ninety.5% against. 93.9%, p = 0.019). Shorter lady with gastric adenocarcinoma received …